Based on preliminary research that has suggested an increased risk for carriers, the NBN gene has been added to breast cancer multigene panels, with the c.657del5 mutation [145] being associated with up to 30% of female breast cancer cases. This evidence concerns the gene NBN and breast carcinoma.